Risikoen for alvorlige relapser efter seponering af Extavia bør i tilfælde af graviditet hos patienter med hyppige relapser før behandlingsstart vægtes mod den mulige øgede risiko for spontan abort.
In patients with a high relapse rate before treatment started, the risk of a severe relapse following discontinuation of Extavia in the event of pregnancy should be weighed against a possible increased risk of spontaneous abortion.